Evidence map›Paper›PMID 39552337›Full record

ArticleDisease models & mechanisms2024

Distinct fingerprints of tRNA-derived small non-coding RNA in animal models of neurodegeneration.

Sharada Baindoor, Hesham A Y Gibriel, Morten T Venø, Junyi Su, Elena Perez Morrissey, Elisabeth Jirström, Ina Woods, Aidan Kenny, Mariana Alves, Luise Halang and 9 more

Abstract read
In one paragraph

Article in Disease models & mechanisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Emerging roles of transfer RNA fragments in the CNS.Brain : a journal of neurology · 2025
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Sharada BaindoorDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin D02 YN77, Ireland.ORCID 0000-0002-6838-7964
Hesham A Y GibrielDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin D02 YN77, Ireland.ORCID 0000-0002-3362-1570
Morten T VenøOmiics ApS, DK-8200 Aarhus N, Denmark.
Junyi SuOmiics ApS, DK-8200 Aarhus N, Denmark.
Elena Perez MorrisseyDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin D02 YN77, Ireland.
Elisabeth JirströmDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin D02 YN77, Ireland.ORCID 0000-0003-4060-3300
Ina WoodsDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin D02 YN77, Ireland.
Aidan KennyDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin D02 YN77, Ireland.ORCID 0000-0001-8674-055X
Mariana AlvesDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin D02 YN77, Ireland.
Luise HalangDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin D02 YN77, Ireland.
Paola FabbrizioLaboratory of Neurobiology and Preclinical Therapeutics, Department of Neuroscience, IRCCS - Mario Negri Institute for Pharmacological Research, Via Mario Negri, 2, 20156 Milan, Italy.ORCID 0000-0003-1843-2605
Maria BilenDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Tobias EngelDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin D02 YN77, Ireland.
Marion C HoggDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin D02 YN77, Ireland.
Caterina BendottiLaboratory of Neurobiology and Preclinical Therapeutics, Department of Neuroscience, IRCCS - Mario Negri Institute for Pharmacological Research, Via Mario Negri, 2, 20156 Milan, Italy.
Giovanni NardoLaboratory of Neurobiology and Preclinical Therapeutics, Department of Neuroscience, IRCCS - Mario Negri Institute for Pharmacological Research, Via Mario Negri, 2, 20156 Milan, Italy.
Ruth S SlackDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Jørgen KjemsInterdisciplinary Nanoscience Centre, Department of Molecular Biology and Genetics, Aarhus University, DK-8000 Aarhus C, Denmark.
Jochen H M PrehnDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin D02 YN77, Ireland.ORCID 0000-0003-3479-7794

Funding

EU Joint Programme - Neurodegenerative Disease ResearchEuropean Regional Development FundFutureNeuroMinistero della Salute SG-2018-12366226Precision ALSRegione Lombardia CUP E48I20000000007Research Ireland 17/JPND/3455Research Ireland Centre for Research Training in Genomics Data Science 18/CRT/6214Royal College of Surgeons in Ireland
6 · The paper itself

Abstract

Transfer RNA-derived small RNAs (tsRNAs) - categorized as tRNA-derived fragments (tRFs), tRNA-derived stress-induced RNAs (tiRNAs) and internal tRF (itRF) - are small non-coding RNAs that participate in various cellular processes such as translation inhibition and responses to cellular stress. We here identified tsRNA profiles within susceptible tissues in animal models of amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and Parkinson's disease (PD) to pinpoint disease-specific tsRNAs and those shared across neurodegenerative diseases. We performed small RNA sequencing in the SOD1G93A and TDP43A315T mouse models of ALS (spinal cord), the TauP301S model of FTD (hippocampus), and the parkin/POLG model of PD (substantia nigra). Bioinformatic analysis showed higher expression of 5' tiRNAs selectively in the two ALS models, lower expression of 3' tRFs in both the ALS and FTD mouse models, and lower expression of itRF Arg in the PD model. Experimental validation confirmed the expression of tsRNAs. Gene Ontology analysis of targets associated with validated 3' tRFs indicated functions in the regulation of synaptic and neuronal pathways. Our profiling of tsRNAs indicates disease-specific fingerprints in animal models of neurodegeneration, which require validation in human disease.

Indexed as

Disease Models, AnimalRNA, Small UntranslatedRNA, TransferAmyotrophic Lateral SclerosisAnimalsFrontotemporal DementiaHumansMiceMice, TransgenicNeurodegenerative DiseasesParkinson DiseaseRNA, Small UntranslatedRNA, TransferAmyotrophic lateral sclerosisFrontotemporal dementiaParkinson's diseasetiRNAtRFtsRNA

Identifiers

PMID39552337
PMCPMC11603119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.